Meera Ragavan, MD, MPH

Title(s)Adjunct Instructor, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue, #M1286
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford School of Medicine MD06/2017
    Harvard T.H Chan School of Public Health MPH05/2016
    University of PennsylvaniaBA/BS05/2011Biology/Economics

    Collapse Overview 
    Collapse Overview
    I am a clinical fellow in the Division of Hematology/Oncology planning on a career in thoracic oncology. I have extensive training in health services research spanning policy evaluation, cost-effectiveness analyses, and implementation science. My research interests are centered around issues of affordability and equity in cancer care delivery and designing and implementing interventions to mitigate these growing challenges, particularly for patients with lung cancer. I also study the impact of telehealth on cancer outcomes and payor-related barriers to timely, high-quality care. I have a BA/BS in biology & economics from the University of Pennsylvania, an MD from Stanford School of Medicine, and an MPH from Harvard T.H Chan School of Public Health.

    Collapse ORNG Applications 
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Screening for comprehensive social needs in patients with cancer: a narrative review. JNCI Cancer Spectr. 2025 Mar 03; 9(2). Arana I, Liu R, Kushi L, Hahn E, Ragavan M. PMID: 39873703; PMCID: PMC11917213.
      View in: PubMed   Mentions:    Fields:    
    2. Band-Aids Can Still Help Heal: The Role of Patient Financial Assistance Programs in Addressing Financial Toxicity. JCO Oncol Pract. 2025 Jan; 21(1):73-77. Ragavan MV, Mora RV, Nipp R, Winestone LE. PMID: 39793545.
      View in: PubMed   Mentions:    Fields:    
    3. Robotic-Assisted Vesicovaginal Fistula Repair: A Comparative Analysis Between Hugo RAS and da Vinci Xi Systems. Int Urogynecol J. 2025 Jan; 36(1):173-176. Sakthivel DK, Ragavan A, Bafna S, Ragavan N, Ragavan M. PMID: 39636466.
      View in: PubMed   Mentions:    Fields:    
    4. Robotic Surgery in Pelvic Organ Prolapse: A Retrospective Comparison of Ileopectopexy and Sacrocolpopexy. Cureus. 2024 Oct; 16(10):e72356. Kannan D, Ragavan A, Tiwari M, Ragavan N, Ragavan M. PMID: 39583429; PMCID: PMC11585913.
      View in: PubMed   Mentions:
    5. Use of the Medtronic Hugo Robot-Assisted Surgery (RAS) System in Urogynecology: A Safety and Feasibility Study of the First 100 Procedures. Cureus. 2024 Oct; 16(10):e72213. Ragavan M, Kannan D, Ragavan A, Tiwari M, Ragavan N. PMID: 39583382; PMCID: PMC11584036.
      View in: PubMed   Mentions:
    6. Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC. J Thorac Oncol. 2025 Jan; 20(1):109-118. Nassar AH, Jayakrishnan R, Feng J, Shepherd F, Adib E, Cheung JM, Lin JJ, Liu Y, Lin SH, Parikh K, Sridhar A, Shakya P, Dilling TJ, Kaldas D, Gray JE, Lobachov A, Bar J, Luders H, Grohe C, Gupta S, Leal T, Fitzgerald B, Crowley F, Fujiwara Y, Marron TU, Wilgucki M, Reuss J, Chen L, Sankar K, Aredo JV, Neal JW, Wakelee HA, Thummalapalli R, Yu H, Whitaker R, Velazquez A, Ragavan M, Cortellini A, Kwiatkowski DJ, Naqash AR, Goldberg SB, Kim SY. PMID: 39260522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis. Mol Diagn Ther. 2024 09; 28(5):525-536. Chen C, Douglas MP, Ragavan MV, Phillips KA, Jansen JP. PMID: 39093546; PMCID: PMC11349784.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Beyond the PSA: The hidden costs of screening in prostate cancer. Cancer. 2024 Oct 01; 130(19):3272-3274. Sanyal C, Ragavan MV. PMID: 39012908.
      View in: PubMed   Mentions:    Fields:    
    9. Receipt of financial assistance for oral targeted therapy among older adults with advanced non-small cell lung cancer: A prospective cohort study. J Geriatr Oncol. 2024 06; 15(5):101746. Kumar A, Ragavan M, Velazquez AI, Zeng S, Wong ML. PMID: 38490915; PMCID: PMC11153012.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program. Support Care Cancer. 2024 Feb 16; 32(3):161. Parikh DA, Rodriguez GM, Ragavan M, Kerr E, Asuncion MK, Hansen J, Srinivas S, Fan AC, Shah S, Patel MI. PMID: 38366165.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study. J Thorac Oncol. 2024 Jun; 19(6):928-940. Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin SH, Abuali T, Amini A, Nie Y, Patil T, Lobachov A, Bar J, Fitzgerald B, Fujiwara Y, Marron TU, Thummalapalli R, Yu H, Owen DH, Sharp J, Farid S, Rocha P, Arriola E, D'Aiello A, Cheng H, Whitaker R, Parikh K, Ashara Y, Chen L, Sankar K, Harris JP, Nagasaka M, Ayanambakkam A, Velazquez AI, Ragavan M, Lin JJ, Piotrowska Z, Wilgucki M, Reuss J, Luders H, Grohe C, Baena Espinar J, Feiner E, Punekar SR, Gupta S, Leal T, Kwiatkowski DJ, Mak RH, Adib E, Naqash AR, Goldberg SB. PMID: 38278303.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Pharmacy Assistance Programs for Oral Anticancer Drugs: A Narrative Review. JCO Oncol Pract. 2024 Apr; 20(4):472-482. Ragavan MV, Swartz S, Clark M, Chino F. PMID: 38241597.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Access to Financial Assistance Programs and Their Impact on Overall Spending on Oral Anticancer Medications at an Integrated Specialty Pharmacy. JCO Oncol Pract. 2024 02; 20(2):291-299. Ragavan MV, Swartz S, Clark M, Lo M, Gupta A, Chino F, Lin TK. PMID: 38175987.
      View in: PubMed   Mentions: 1     Fields:    
    14. Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis. medRxiv. 2023 Oct 28. Chen C, Douglas MP, Ragavan MV, Phillips KA, Jansen JP. PMID: 37961510; PMCID: PMC10635208.
      View in: PubMed   Mentions:
    15. The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis. Value Health. 2023 12; 26(12):1697-1710. Jansen JP, Ragavan MV, Chen C, Douglas MP, Phillips KA. PMID: 37741446; PMCID: PMC10859998.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment. J Natl Compr Canc Netw. 2023 06; 21(6):609-616.e4. Douglas MP, Ragavan MV, Chen C, Kumar A, Gray SW, Blakely CM, Phillips KA. PMID: 37308126; PMCID: PMC10846388.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. The costs and inequities of precision medicine for patients with prostate cancer: A call to action. Urol Oncol. 2023 09; 41(9):369-375. Ragavan MV, Borno HT. PMID: 37164775.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic. JAMA Oncol. 2022 12 01; 8(12):1849-1851. Ragavan MV, Legaspi N, LaLanne A, Hong JC, Small EJ, Borno HT. PMID: 36301577; PMCID: PMC9614670.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    19. Impact of a Comprehensive Financial Resource on Financial Toxicity in a National, Multiethnic Sample of Adult, Adolescent/Young Adult, and Pediatric Patients With Cancer. JCO Oncol Pract. 2023 02; 19(2):e286-e297. Ragavan MV, Mora RV, Winder K, Incudine A, Cunningham R, Stivers T, Borno HT. PMID: 36378994.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    20. Estimating maternity ward birth attendant time use in India: a microcosting study. BMJ Open. 2022 Feb 07; 12(2):e054164. Lofgren KT, Bobanski L, Tuller DE, Singh VP, Marx Delaney M, Jurczak A, Ragavan M, Kalita T, Karlage A, Resch SC, Semrau KEA. PMID: 35131826; PMCID: PMC8823136.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    21. The evolving landscape of sex-based differences in lung cancer: a distinct disease in women. Eur Respir Rev. 2022 Mar 31; 31(163). Ragavan M, Patel MI. PMID: 35022255; PMCID: PMC9488944.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    22. Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems. JCO Oncol Pract. 2021 10; 17(10):e1450-e1459. Parikh DA, Ragavan M, Dutta R, Garnet Edwards J, Dickerson J, Maitra D, Aggarwal S, Lee FC, Patel MI. PMID: 33826366; PMCID: PMC9797228.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    23. Defining the clinician's role in mitigating financial toxicity: an exploratory study. Support Care Cancer. 2021 Aug; 29(8):4835-4845. Ragavan M, Parikh D, Patel M. PMID: 33544246; PMCID: PMC8340663.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Healthcare delivery interventions to reduce cancer disparities worldwide. World J Clin Oncol. 2020 Sep 24; 11(9):705-722. Dickerson JC, Ragavan MV, Parikh DA, Patel MI. PMID: 33033693; PMCID: PMC7522545.
      View in: PubMed   Mentions: 12  
    25. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy. Curr Treat Options Oncol. 2020 06 29; 21(8):64. Ragavan M, Das M. PMID: 32601742.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    26. Understanding sex disparities in lung cancer incidence: are women more at risk? Lung Cancer Manag. 2020 Jun 22; 9(3):LMT34. Ragavan MV, Patel MI. PMID: 32774466; PMCID: PMC7399577.
      View in: PubMed   Mentions: 11  
    27. Association Between HEDIS Performance and Primary Care Physician Age, Group Affiliation, Training, and Participation in ACA Exchanges. J Gen Intern Med. 2020 06; 35(6):1730-1735. Glassman JR, Hopkins DSP, Bundorf MK, Kaplan RM, Ragavan MV, Glaseroff A, Milstein A. PMID: 31974901; PMCID: PMC7280418.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value. J Am Soc Nephrol. 2019 12; 30(12):2464-2472. Brady BM, Ragavan MV, Simon M, Chertow GM, Milstein A. PMID: 31727849; PMCID: PMC6900798.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Barriers to timely discharge from the general medicine service at an academic teaching hospital. Postgrad Med J. 2017 Sep; 93(1103):528-533. Ragavan MV, Svec D, Shieh L. PMID: 28450581.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    30. Scheduled surgery admissions and occupancy at a children's hospital: variation we can control to improve efficiency and value in health care delivery. Ann Surg. 2013 Mar; 257(3):564-70. Ragavan MV, Blinman TA, Fieldston ES. PMID: 22968076.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Traditional measures of hospital utilization may not accurately reflect dynamic patient demand: findings from a children's hospital. Hosp Pediatr. 2012 Jan; 2(1):10-8. Fieldston E, Ragavan M, Jayaraman B, Metlay J, Pati S. PMID: 24319808.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Scheduled admissions and high occupancy at a children's hospital. J Hosp Med. 2011 Feb; 6(2):81-7. Fieldston ES, Ragavan M, Jayaraman B, Allebach K, Pati S, Metlay JP. PMID: 21290580.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Meera's Networks
    Concepts (132)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.